How Valeant Gave Itself Extra Time to File Delayed Financials

  • Drugmaker breached bond pact last week, Covenant Review says
  • Company says it had until May 16 to file financial report

A debt-research firm says Valeant Pharmaceuticals International Inc. has been budgeting more time than it’s actually had to file its financial statements.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.